Sohag Faculty of Medicine
Sohag, Sohag Governorate, 82511, Egypt
Location status: Recruiting
NCT Number: NCT07363889
The aim of our study is to compare between two techniques used for active SOR. The outcomes include efficiency and safety.
Patients with silicon filled eyes and prepared for SOR 540 eyes of 505 patients (one eye in 470 patients, and both eyes in 35 patients) were enrolled in the study.
All eyes underwent SOR using 23-Gauge PPV. The eyes were classified according to the surgical technique used for SOR into two groups:- Group A: SOR was performed using SO extraction program built in Optikon vitrectomy device Group B: SOR was performed using modified spring loaded syringe.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Sohag, Sohag Governorate, 82511, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Active silicon oil extraction through 23G pars plana system vitrectomy machine
5 mml syringe with spring in its plunger and rubber connection
Time frame: During the surgical procedure and up to 3 months postoperative
Incidence of operative and postoperative complications in both groups
Time frame: From beginning of silicon oil extraction until complete extraction, It is recorded for every individual surgical procedure
Total time in seconds needed to completely remove silicon oil, it is recorded by an assistant.
Contact information is provided by the study sponsor or research team.
Sohag University
Other
Vitrectomy Machine Versus Spring Loaded Syringe for Active Silicon Oil Extraxtion
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731984
Eye Diseases, Retinal Detachment
Sohag, Egypt
View Trial DetailsNCT02423213
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT07500324
Age-related Macular Degeneration (AMD), Cardiovascular Diseases
Roma, Italy
View Trial DetailsNCT06587945
Eye Diseases, Retinal Detachment
East Melbourne, Victoria, Australia
View Trial Details